Authors: Wassef, AA Hafiz, NG Hampton, D Molloy, M

Citation: Aa. Wassef et al., Divalproex sodium augmentation of haloperidol in hospitalized patients with schizophrenia: Clinical and economic implications, J CL PSYCH, 21(1), 2001, pp. 21-26

Authors: Wassef, AA Dott, SG Harris, A Brown, A O'Boyle, M Meyer, WJ Rose, RM

Citation: Aa. Wassef et al., Randomized, placebo-controlled pilot study of divalproex sodium in the treatment of acute exacerbations of chronic schizophrenia, J CL PSYCH, 20(3), 2000, pp. 357-361

Authors: Wassef, AA

Citation: Aa. Wassef, GABAergic drugs in schizophrenia, PHARM TOXIC, 2000, pp. 153-161

Authors: Wassef, AA Dott, SG Harris, A Brown, A O'Boyle, M Meyer, WJ Rose, RM

Citation: Aa. Wassef et al., Critical review of GABA-ergic drugs in the treatment of schizophrenia, J CL PSYCH, 19(3), 1999, pp. 222-232